12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Namenda regulatory update

EMA's CHMP issued positive opinions recommending approval of generic versions of memantine from Mylan Inc. (NASDAQ:MYL, Canonsburg, Pa.) and Actavis Inc. (NYSE:ACT, Parsippany,...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >